Nykode Therapeutics (Norway) Market Value
| NYKD Stock | 2.17 0.10 4.41% |
| Symbol | Nykode |
Nykode Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nykode Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nykode Therapeutics.
| 12/16/2024 |
| 03/16/2025 |
If you would invest 0.00 in Nykode Therapeutics on December 16, 2024 and sell it all today you would earn a total of 0.00 from holding Nykode Therapeutics ASA or generate 0.0% return on investment in Nykode Therapeutics over 90 days.
Nykode Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nykode Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nykode Therapeutics ASA upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 26.88 | |||
| Value At Risk | (5.90) | |||
| Potential Upside | 7.31 |
Nykode Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nykode Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nykode Therapeutics' standard deviation. In reality, there are many statistical measures that can use Nykode Therapeutics historical prices to predict the future Nykode Therapeutics' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | 0.2324 | |||
| Treynor Ratio | (0.52) |
Nykode Therapeutics ASA Backtested Returns
Nykode Therapeutics ASA has Sharpe Ratio of -0.14, which conveys that the firm had a -0.14 % return per unit of risk over the last 3 months. Nykode Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nykode Therapeutics' Mean Deviation of 3.38, standard deviation of 4.48, and Risk Adjusted Performance of (0.05) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.64, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Nykode Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Nykode Therapeutics is expected to be smaller as well. At this point, Nykode Therapeutics ASA has a negative expected return of -0.57%. Please make sure to verify Nykode Therapeutics' total risk alpha, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if Nykode Therapeutics ASA performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.35 |
Below average predictability
Nykode Therapeutics ASA has below average predictability. Overlapping area represents the amount of predictability between Nykode Therapeutics time series from 16th of December 2024 to 30th of January 2025 and 30th of January 2025 to 16th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nykode Therapeutics ASA price movement. The serial correlation of 0.35 indicates that nearly 35.0% of current Nykode Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.35 | |
| Spearman Rank Test | 0.34 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Nykode Therapeutics ASA lagged returns against current returns
Autocorrelation, which is Nykode Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nykode Therapeutics' stock expected returns. We can calculate the autocorrelation of Nykode Therapeutics returns to help us make a trade decision. For example, suppose you find that Nykode Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Nykode Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nykode Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nykode Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nykode Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Nykode Therapeutics Lagged Returns
When evaluating Nykode Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nykode Therapeutics stock have on its future price. Nykode Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nykode Therapeutics autocorrelation shows the relationship between Nykode Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Nykode Therapeutics ASA.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio Architect